Header Logo

Connection

MICHAEL TAYLOR to Cyclin-Dependent Kinase Inhibitor p27

Back to Details
This is a "connection" page, showing publications MICHAEL TAYLOR has written about Cyclin-Dependent Kinase Inhibitor p27.
MICHAEL TAYLOR
Connection Strength
0.078
Cyclin-Dependent Kinase Inhibitor p27
  1. Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization. Cancer Res. 2009 Sep 15; 69(18):7224-34.
    View in: PubMed
    Score: 0.078
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.